Accession Number:

AD1036821

Title:

A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients With High-Risk Castrate, Biochemically Relapsed Prostate Cancer

Descriptive Note:

Technical Report,17 Aug 2015,16 Aug 2016

Corporate Author:

CORNELL UNIV MEDICAL COLL (WEILL) NEW YORK NEW YORK United States

Personal Author(s):

Report Date:

2016-09-01

Pagination or Media Count:

136.0

Abstract:

Clinical trial has received WCMC IRB and CTSC approval with enrollment of initial 6 subjects at WCMC. An additional 38 subjects enrolled 29 treated at participating sub-sites. Reports submitted to WCMC DSMB in December 2014 with approval to proceed without modifications.

Subject Categories:

  • Radiobiology
  • Pharmacology
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE